CERS5 and colonic neoplasm: In addition, treatment with either oxaliplatin or 5-fluorouracil dramatically increases CerS5 transcription in HCT-116 colon cancer cells, but this effect is abrogated when p53 is ablated (82), indicating that p53 is likely an upstream regulator of CerS5.